Section_No,Section_Name,Medicine_Name,Dosage_Form_and_Strength,List_Type
,,Ampoule  In 8%  Glucose Solution.,Therapeutic alternatives to be reviewed   Injection:  0.5%  [c]; 1%; 2% (hydrochloride).,Core
,,Ampoule  In 8%  Glucose Solution.,Injection for spinal anaesthesia:  5% (hydrochloride) in  2 mL,Core
,,Ampoule  Or Vial .,Therapeutic alternatives to be reviewed   Injection:  1 mg/mL in 5 mL vial ; 5 mg/mL in 1  mL or 3  mL vial .,Complementary
,,Ampoule  Or Vial .,Oral liquid : 2 mg/mL [c].,Complementary
,,Ampoule  Or Vial .,morphine  Injection:  1 mg/mL  [c]; 2 mg/mL [c]; 10 mg/mL (sulfate  or,Complementary
,,Ampoule In 7.5% Glucose Solution.,Injection:  1%; 2% (hydrochloride or sulfate) + epinephrine,Core
,,Ampoule In 7.5% Glucose Solution.,ephedrine * Injection:  30 mg/mL (hydrochloride ) in 1 mL ampoule.,Complementary
,,Ampoule In 7.5% Glucose Solution.,atropine  Injection:  400 micrograms/mL  [c]; 1 mg/mL (sulfate) in 1  mL,Complementary
,,Derivatives) (For Amlodipine),*including quality -assured biosimilars  Injection solution: 0.68 mg/mL; 1.34  mg/mL.,Core
,,Derivatives) (For Amlodipine),*including quality -assured biosimilars  Injection solution: 0.68 mg/mL; 1.34  mg/mL ; 2.68  mg/mL .,Core
,,Sevoflurane  Inhalation.,ketamine  Injection: 10 mg/mL  [c]; 50 mg/mL (as hydrochloride)  in vial.,Core
,,Sevoflurane  Inhalation.,- thiopental  Injection: 10 mg/mL; 20 mg/mL.,Core
,,Sevoflurane  Inhalation.,Therapeutic alternatives to be reviewed   Injection:  0.25%; 0.5% (hydrochloride).,Core
,,Sevoflurane  Inhalation.,Injection for spinal anaesthesia:  0.5% (hydrochloride) in  4 mL,Core
,,Standards/Standards -And-Specifications/Norms -And-Standards -For-Pharmaceuticals/International -Pharmacopoeia .,1.1.1 Inhalational medicines,Core
10,Medicines Affecting The Blood,Acid.*,Tablet:  equivalent to 60  mg elemental iron + 2.8  mg folic acid .**,Core
10,Medicines Affecting The Blood,Acid.*,folic acid  Oral liquid : 1 mg/mL [c].,Core
10,Medicines Affecting The Blood,Acid.*,Tablet:  400 micrograms*; 1 mg; 5  mg.,Core
10,Medicines Affecting The Blood,Ampoule  Or Vial .,phytomenadione  Injection:  1 mg/0.5mL [c]; 1 mg/mL [c]; 10 mg/mL in ampoule.,Complementary
10,Medicines Affecting The Blood,Ampoule  Or Vial .,Injection (mixed micelle solution): 2 mg/0.2 mL; 10 mg/mL in,Complementary
10,Medicines Affecting The Blood,Ampoule .,Tablet:  5 mg.,Complementary
10,Medicines Affecting The Blood,Ampoule .,protamine sulfate  Injection:  10 mg/mL in 5 mL ampoule  or vial .,Complementary
10,Medicines Affecting The Blood,Ampoule .,tranexamic acid  Injection:  100 mg/mL in 10  mL ampoule.,Complementary
10,Medicines Affecting The Blood,Ampoule .,- acenocoumarol   Tablet  (scored) : 1 mg; 2  mg; 3 mg; 5 mg (sodium).,Complementary
10,Medicines Affecting The Blood,Ampoule .,heparin sodium  [c] Injection:  1000  IU/mL; 5000  IU/mL in 1 mL ampoule  or vial .,Complementary
10,Medicines Affecting The Blood,Ampoule .,protamine sulfate [c] Injection:  10 mg/mL in 5 mL ampoule  or vial .,Complementary
10,Medicines Affecting The Blood,Ampoule .,- acenocoumarol  Tablet  (scored) : 0.5 mg; 1  mg; 2  mg; 3 mg; 5 mg (sodium).,Complementary
10,Medicines Affecting The Blood,Ampoule .,- deferiprone  Tablet (dispersible):  100 mg; 125 mg; 250 mg; 400 mg; 500 mg.,Complementary
10,Medicines Affecting The Blood,Ampoule .,Tablet (film -coated):  90 mg; 180 mg; 360 mg.,Complementary
10,Medicines Affecting The Blood,Ampoule .,deferoxamine  Powder for injection:  500 mg (mesilate) in vial.,Complementary
10,Medicines Affecting The Blood,Ampoule .,- deferiprone  Tablet (dispersible):  100 mg; 125  mg; 250  mg; 400  mg; 500  mg.,Complementary
10,Medicines Affecting The Blood,Ampoule .,Tablet (film -coated):  90 mg; 180  mg; 360  mg.,Complementary
10,Medicines Affecting The Blood,Defects .,"WHO Model List of Essential Medicines – 24th List (2025 ) page 37 hydroxocobalamin  Injection:  1 mg/mL (as acetate, as hydrochloride  or as sulfate) in",Core
10,Medicines Affecting The Blood,Defects .,Injection: pre-filled syringe,Complementary
10,Medicines Affecting The Blood,Defects .,Capsule: 110 mg; 150  mg.,Complementary
10,Medicines Affecting The Blood,Defects .,desmopressin  [c] Injection : 4 micrograms/mL (acetate) in 1  mL ampoule.,Complementary
10,Medicines Affecting The Blood,Defects .,emicizumab  Injection: 12 mg/0.4  mL [c]; 30 mg/mL  [c]; 60 mg/0.4  mL;,Complementary
10,Medicines Affecting The Blood,Defects .,*including quality -assured biosimilars  Injection:  ampoule or pre -filled syringe,Complementary
10,Medicines Affecting The Blood,Defects .,heparin sodium  Injection:  1000  IU/mL; 5000  IU/mL; 20 000 IU/mL in 1 mL,Complementary
10,Medicines Affecting The Blood,Malnutrition And C Odex Alimentarius Guidelines.,ferrous salt  Oral liquid:  equivalent to 9 mg/mL elemental iron  [c]; equivalent to,Core
10,Medicines Affecting The Blood,Malnutrition And C Odex Alimentarius Guidelines.,Tablet:  equivalent to 60  mg – 65 mg elemental iron.,Core
10,Medicines Affecting The Blood,Malnutrition And C Odex Alimentarius Guidelines.,ferrous salt + folic acid  Tablet : equivalent to 60  mg elemental iron + 400  micrograms folic,Core
11,"Blood Products , Coagulation Factors,  And Plasma Substitutes",Of Life-Threatening Haemorrhage When Pathogen -Reduced,cryoprecipitate is not available.  Injection : frozen liquid in bag or lyophilized powder in vial,Core
11,"Blood Products , Coagulation Factors,  And Plasma Substitutes",Whole Blood,anti-D immunoglobulin  Injection:  250 micrograms in single -dose vial.,Core
11,"Blood Products , Coagulation Factors,  And Plasma Substitutes",Whole Blood,anti-rabies immunoglobulin   Injection:  150 IU/mL in vial.,Core
11,"Blood Products , Coagulation Factors,  And Plasma Substitutes",Whole Blood,anti-tetanus immunoglobulin  Injection:  500 IU in vial.,Core
11,"Blood Products , Coagulation Factors,  And Plasma Substitutes",Whole Blood,"coagulation factor VIII , plasma -derived   Powder for injection: 250 IU; 500  IU; 1000  IU in vial.",Complementary
11,"Blood Products , Coagulation Factors,  And Plasma Substitutes",Whole Blood,"coagulation factor IX , plasma -derived   Powder for injection: 500 IU; 1000  IU in vial.",Complementary
12,Cardiovascular Medicines,Atorvastatin),"inhibitors, plain) (for ramipril)  Tablet: 100 mg + 20 mg + 2.5  mg; 100 mg + 20 mg + 5 mg;",Complementary
12,Cardiovascular Medicines,Efficacy And Safety Of Other Medicines.,Oral liquid: 50 mg/5  mL.,Complementary
12,Cardiovascular Medicines,Hypertension In Patients >  60 Years,"inhibitors, plain)  Oral liquid: 1 mg/mL (as hydrogen maleate) [c].",Complementary
12,Cardiovascular Medicines,Hypertension In Patients >  60 Years,Tablet:  2.5 mg; 5  mg; 10 mg (as hydrogen maleate).,Complementary
12,Cardiovascular Medicines,Hypertension In Patients >  60 Years,hydralazine * Powder for injection : 20 mg (hydrochloride) in ampoule.,Complementary
12,Cardiovascular Medicines,Hypertension In Patients >  60 Years,Tablet:  25 mg; 50  mg (hydrochloride).,Complementary
12,Cardiovascular Medicines,In 10  Ml Ampoule.,lidocaine  Injection:  20 mg/mL (hydrochloride)  in 5 mL ampoule.,Core
12,Cardiovascular Medicines,In 10  Ml Ampoule.,WHO Model List of Essential Medicines – 24th List (2025 ) page 40 verapamil  Injection:  2.5 mg/mL (hydrochloride)  in 2 mL ampoule.,Core
12,Cardiovascular Medicines,In 10  Ml Ampoule.,Tablet:  40 mg; 80  mg (hydrochloride).,Core
12,Cardiovascular Medicines,In 10  Ml Ampoule.,amiodarone  Injection:  50 mg/mL (hydrochloride ) in 3 mL ampoule.,Complementary
12,Cardiovascular Medicines,In 10  Ml Ampoule.,Tablet: 100 mg; 200  mg; 400  mg (hydrochloride).,Complementary
12,Cardiovascular Medicines,In 10  Ml Ampoule.,"Dihydropyridine derivatives)  Tablet:  5 mg (as maleate, mesylate  or besylate).",Complementary
12,Cardiovascular Medicines,In 10  Ml Ampoule.,- metoprolol  Tablet: 1.25 mg; 5  mg.,Complementary
12,Cardiovascular Medicines,"Inhibitors, Plain)  (For Lisinopril)",Dihydropyridine derivatives)  (for amlodipine)  Tablet: 10 mg + 5  mg; 20  mg + 5  mg; 20  mg + 10  mg.,Complementary
12,Cardiovascular Medicines,"Inhibitors, Plain)  (For Lisinopril)",hydrochlorothiazide ) Tablet: 10 mg + 12.5  mg; 20  mg + 12.5  mg; 20  mg + 25  mg.,Complementary
12,Cardiovascular Medicines,"Inhibitors, Plain)  (For Lisinopril)","receptor blockers (ARBs), plain)  Tablet:  25 mg; 50  mg; 100  mg.",Complementary
12,Cardiovascular Medicines,"Inhibitors, Plain)  (For Lisinopril)",methyldopa * Tablet: 250 mg.,Complementary
12,Cardiovascular Medicines,"Inhibitors, Plain) (For Perindopril)",Dihydropyridine derivatives) (for amlodipine)  Tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg +,Complementary
12,Cardiovascular Medicines,"Inhibitors, Plain) (For Ramipril)",hydrochlorothiazide)  Tablet:  100 mg + 20 mg + 5 mg + 50 mg + 12.5  mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Telmisartan)",Dihydropyridine derivatives)  (for amlodipine ) Tablet: 40 mg + 5  mg; 80  mg + 5  mg; 80  mg + 10  mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Telmisartan)",hydrochlorothiazide ) Tablet: 40 mg + 12.5  mg; 80  mg + 12.5  mg; 80  mg + 25  mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",sodium nitroprusside  Powder for infusion:  50 mg in ampoule.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",- metoprolol  Tablet: 1.25 mg; 5  mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",WHO Model List of Essential Medicines – 24th List (2025 ) page 42 digoxin  Injection:  250 micrograms /mL in 2 mL ampoule.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",Oral liquid:  50 micrograms /mL.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",Tablet:  62.5 micrograms ; 250  micrograms .,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)","inhibitors, plain)  Tablet:  2.5 mg; 5 mg; 10 mg (as hydrogen maleate).",Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)","Injection:  10 mg/mL in 2 mL, 5 mL ampoule.",Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",Oral liquid:  20 mg/5 mL; 50 mg/5 mL [c].,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",Tablet:  20 mg; 40 mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",- indapamid e Oral liquid: 50 mg/5 mL.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)","receptor blockers (ARBs), plain)  Tablet:  25 mg; 50 mg; 100  mg.",Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",spironolactone  Tablet:  25 mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",digoxin  [c] Injection: 100 micrograms /mL in 1  mL ampoule;,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",Oral liquid: 50 micrograms /mL.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",Tablet: 62.5 micrograms ; 125  micrograms ; 250  micrograms .,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",dopamine  Injection:  40 mg/mL (hydrochloride) in 5  mL vial.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",acetylsalicylic acid   Tablet:  100 mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",clopidogrel   Tablet:  75 mg; 300  mg.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",alteplase  Powder for injection: 10 mg; 20 mg; 50 mg in vial .,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",streptokinase  Powder for injection:  1.5 million IU in vial.,Complementary
12,Cardiovascular Medicines,"Receptor Blockers (Arbs), Plain)  (For Valsartan)",- pravastatin  Tablet:  5 mg; 10 mg; 20 mg; 40 mg.,Complementary
12,Cardiovascular Medicines,Whole Blood,Tablet:  1.25 mg; 5  mg.,Core
12,Cardiovascular Medicines,Whole Blood,glyceryl trinitrate  Tablet (sublingual):  500 micrograms.,Core
12,Cardiovascular Medicines,Whole Blood,isosorbide dinitrate  Tablet (sublingual):  5 mg.,Core
12,Cardiovascular Medicines,Whole Blood,verapamil  Tablet : 40 mg; 80  mg (hydrochloride).,Core
12,Cardiovascular Medicines,Whole Blood,digoxin  Injection:  250 micrograms/ mL in 2 mL ampoule.,Core
12,Cardiovascular Medicines,Whole Blood,Oral liquid:  50 micrograms/ mL.,Core
12,Cardiovascular Medicines,Whole Blood,Tablet:  62.5 micrograms; 250  micrograms.,Core
12,Cardiovascular Medicines,Whole Blood,epinephrine (adrenaline)  Injection: 100 micrograms/ mL (as acid tartrate  or hydrochloride),Core
13,Dermatological  Medicines,And Triazole Derivatives) Excluding Combinations,sodium thiosulfate  Solution:  15%.,Core
13,Dermatological  Medicines,Calamine  Lotion.,coal tar  Solution:  5%.,Core
13,Dermatological  Medicines,Calamine  Lotion.,- podophyllotoxin  Solution:  10% to 25%.,Core
13,Dermatological  Medicines,Calamine  Lotion.,salicylic acid  Solution:  5%.,Core
13,Dermatological  Medicines,Calamine  Lotion.,*including quality -assured biosimilars  Injection:  10 mg/0.2  mL [c]; 20 mg/0.2 mL [c]; 20 mg/0  .4 mL [c];,Complementary
13,Dermatological  Medicines,Pre-Filled Pen .,methotrexate  Tablet : 2.5 mg; 10 mg (as sodium) .,Complementary
13,Dermatological  Medicines,Ustekinumab *,"*including quality -assured biosimilars  Injection:  45 mg/0.5  mL in vial , pre-filled syringe , or pre -filled pen;",Complementary
14,Diagnostic Agents,A > 2 Years.,Therapeutic alternatives  to be reviewed   Injection:  140 mg to 420  mg iodine/ mL (as sodium  or meglumine,Core
14,Diagnostic Agents,Barium Sulfate  Aqueous Suspension.,"Therapeutic alternatives  to be reviewed   Injection:  140 mg to 350  mg iodine/ mL in 5 mL, 10 mL, 20 mL",Core
14,Diagnostic Agents,Barium Sulfate [C] Aqueous Suspension.,Therapeutic alternatives to be reviewed   Solution:  5 g to 8 g iodine in 100  mL to 250  mL.,Complementary
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,Therapeutic alternatives  to be reviewed   Solution:  5% (digluconate).,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,- propanol  Solution:  70% (denatured).,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,- iodine  Solution:  10%  (equivalent to 1% available iodine).,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,alcohol base d hand rub  Solution : containing ethanol 80% v olume/volume .,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,Solution : containing i sopropyl alcohol 75% volume/volume .,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,Powder:  (0.1% available chlorine) for solution.,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,derivatives)  Solution:  4.8%.,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,glutaral  Solution:  2%.,Core
15,Antiseptics  And Disinfectants,Barium Sulfate [C] Aqueous Suspension.,hypochlorous acid  Solution  (aqueous):  containing hypochlorous acid ≥ 150 parts per,Core
16,Diuretics,Million.,amiloride  Tablet:  5 mg (hydrochloride).,Core
16,Diuretics,Million.,"- torasemide  Injection : 10 mg/mL in 2 mL, 5 mL ampoule.",Core
16,Diuretics,Million.,Oral liquid:  20 mg/5 mL; 50 mg/5 mL [c].,Core
16,Diuretics,Million.,Tablet : 20 mg; 40 mg.,Core
16,Diuretics,Million.,spironolactone  Tablet:  25 mg.,Core
16,Diuretics,Million.,mannitol  [c] Solution for infusion : 10%; 20%.,Complementary
16,Diuretics,Million.,spironolactone  [c] Oral liquid:  25 mg/5 mL.,Complementary
16,Diuretics,Million.,Tablet:  12.5 mg; 25 mg.,Complementary
17,Gastrointestinal Medicines,Base) .,metoclopramide  Injection:  5 mg/mL (hydrochloride) in 2 mL ampoule.,Complementary
17,Gastrointestinal Medicines,Base) .,Oral liquid:  5 mg/5  mL [c].,Complementary
17,Gastrointestinal Medicines,Base) .,Tablet  (scored) : 10 mg (hydrochloride).,Complementary
17,Gastrointestinal Medicines,Base) .,"- tropisetron  Injection: 2 mg/mL in 2 mL, 4 mL ampoule (as hydrochloride",Complementary
17,Gastrointestinal Medicines,Dihydrate ).,Oral liquid: 4 mg/5 mL (as hydrochloride dihydrate) .,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,aprepitant  Capsule: 80 mg; 125  mg; 165  mg,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,Powder for oral suspension: 125 mg in sachet,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,Suppository:  500 mg.,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,Tablet:  500 mg.,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,Suppository:  25 mg (acetate).,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,- bisacodyl  Tablet:  7.5 mg (sennosides) (or traditional dosage forms).,Complementary
17,Gastrointestinal Medicines,Dihydrate) .,oral rehydration salts  Powder for dilution  in 200  mL; 500  mL; 1 L.,Complementary
17,Gastrointestinal Medicines,Million.,pancreatic enzymes  [c] Capsule (modified release) *: 10 000 lipase units + 800 0 amylase,Complementary
17,Gastrointestinal Medicines,Only When Manufactured For Immediate Use.,"zinc sulfate * Tablet (dispersible, scored) : 20 mg.",Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,inhibitors) excluding combinations   Powder for injection:  40 mg in vial .,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,Powder for oral liquid: 1 mg/mL; 4  mg/mL .,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,antagonists) excluding combinations  Injection:  25 mg/mL (as hydrochloride) in 2  mL ampoule.,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,Oral liquid:  75 mg/5 mL (as hydrochloride) .,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,Tablet : 150 mg (as hydrochloride).,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,dexamethasone  Injection:  4 mg/mL dexamethasone phosphate  (as sodium,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,Oral liquid:  0.5 mg/5 mL; 2 mg/5 mL (as sodium phosphate) .,Complementary
17,Gastrointestinal Medicines,Units + 100 0 Protease Units.,Tablet : 0.5 mg; 0.75  mg; 1.5  mg; 2 mg; 4 mg (as dexamethasone,Complementary
18,Medicines For Endocrine Disorders,Available,- bromocriptine  Tablet: 0.5 mg; 1 mg.,Complementary
18,Medicines For Endocrine Disorders,Available,octreotide  Injection (immediate -release): 0.05 mg/mL; 0.1 mg/mL;,Complementary
18,Medicines For Endocrine Disorders,Available,Injection ( modified -release ): 20 mg (as acetate)  in vial  plus,Complementary
18,Medicines For Endocrine Disorders,Cartridge Or Pre -Filled Pen.,*including quality -assured biosimilars  Injection solution: 100 IU/mL in 10  mL vial; 100  IU/mL in 3  mL,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Intermediate -Acting) *",*including quality -assured biosimilars  Injection suspension:  40 IU/mL in 10  mL vial; 100  IU/mL in 10  mL,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",*including quality -assured biosimilars  Injection  solution : 40 IU/mL in 10  mL vial; 100  IU/mL in 10  mL vial;,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",- dapagliflozin  Tablet: 10 mg; 25 mg.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",metformin  Tablet:  500 mg (hydrochloride).,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",*including quality -assured biosimilars  Injection  solution : 0.68 mg/mL; 1.34  mg/mL ; 2.68 mg/mL .,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",metformin  [c] Tablet: 500 mg (hydrochloride).,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",glucagon  Injection: 1 mg/mL  as powder and diluent .,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",diazoxide  [c] Oral liquid: 50 mg/mL.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",Tablet:  50 mg.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",levothyroxine  Tablet:  25 micrograms  [c]; 50 micrograms ; 100  micrograms,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",potassium iodide  Tablet  (scored) : 65 mg.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*","- carbimazole (depending on local availability)  Tablet:  5mg, 10mg.",Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",propylthiouracil * Tablet:  50 mg.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",[c] Oral liquid  (aqueous) : 5% w/v + 10% w /v.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",- carbimazole (depending on local availability)  Tablet: 5  mg; 10 mg.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",potassium iodide   [c] Tablet  (scored) : 65 mg.,Complementary
18,Medicines For Endocrine Disorders,"Insulin (Human, Short -Acting )*",propylthiouracil*  [c] Tablet:  50 mg.,Complementary
18,Medicines For Endocrine Disorders,Rehydration Salts.,fludrocortisone  Oral liquid: 100 micrograms/mL (acetate) [c].,Core
18,Medicines For Endocrine Disorders,Rehydration Salts.,Tablet: 100 micrograms  (acetate).,Core
18,Medicines For Endocrine Disorders,Rehydration Salts.,hydrocortisone  Granules: 0.5 mg; 1 mg; 2 mg; 5 mg in capsule [c].,Core
18,Medicines For Endocrine Disorders,Rehydration Salts.,Tablet: 5 mg; 10 mg; 20 mg.,Core
18,Medicines For Endocrine Disorders,Rehydration Salts.,- prednisone  Tablet:  1 mg.,Core
18,Medicines For Endocrine Disorders,Rehydration Salts.,testosterone  Injection:  200 mg (enanthate) in 1  mL ampoule.,Complementary
18,Medicines For Endocrine Disorders,Rehydration Salts.,- norethisterone  Tablet:  5 mg.,Complementary
18,Medicines For Endocrine Disorders,Rehydration Salts.,*including quality -assured biosimilars  Injection solution:  100 IU/mL in 10  mL vial; 100  IU/mL in 3  mL,Complementary
19,Immunologicals,Anti-Rabies Virus Monoclonal Antibodies *,"*including quality -assured biosimilars  Injection: 40 IU/mL in 1.25  mL, 2.5 mL vial; 100  IU/mL in 2.5  mL",Core
19,Immunologicals,Antivenom Immunoglobulin * Injection.,diphtheria antitoxin  Injection:  10 000 IU; 20 000 IU in vial.,Core
19,Immunologicals,Antivenom Immunoglobulin * Injection.,equine rabies immunoglobulin  Injection : 150 IU/mL; 200  IU/mL; 300  IU/mL; 400  IU/mL in vial .,Core
19,Immunologicals,Vial (Human) .,"Injection: 300 IU/mL in 10  mL vial; 600  IU/mL in 1  mL, 2.5 mL and",Core
2,Medicines For Pain And Palliative Care,Administration Is Not Available.,Oral liquid: 2 mg/mL [c].,Core
2,Medicines For Pain And Palliative Care,Administration Is Not Available.,"Solution for oromucosal administration: 5 mg/mL in 0.5  mL, 1  mL,",Core
2,Medicines For Pain And Palliative Care,Administration Is Not Available.,"- tropisetron  Injection: 2 mg/mL in 2 mL, 4 mL ampoule (as hydrochloride",Core
2,Medicines For Pain And Palliative Care,Base) .,diazepam  Injection: 5 mg/mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,Oral liquid: 2 mg/5  mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,Tablet  (scored) : 2 mg [c]; 5 mg; 10  mg.,Core
2,Medicines For Pain And Palliative Care,Base) .,docusate sodium  Capsule: 100 mg.,Core
2,Medicines For Pain And Palliative Care,Base) .,Oral liquid: 12.5 mg/5  mL [c]; 50 mg/5  mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,haloperidol  Injection:  5 mg in 1  mL ampoule.,Core
2,Medicines For Pain And Palliative Care,Base) .,Oral liquid:  2 mg/mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,hyoscine butylbromide  Injection:  20 mg/mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,hyoscine hydrobromide [c]  Injection: 400 micrograms/ mL; 600  micrograms/ mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,lactulose [c]  Oral liquid: 3.3 to 3.4 g/5 mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,metoclopramide  Injection: 5 mg/mL  (hydrochloride)  in 2 mL ampoule.,Core
2,Medicines For Pain And Palliative Care,Base) .,Oral liquid: 5 mg/5  mL.,Core
2,Medicines For Pain And Palliative Care,Base) .,"midazolam  Injection *: 1 mg/mL in 5 mL vial; 5 mg/mL in 1 mL, 3  mL vial .",Core
2,Medicines For Pain And Palliative Care,Dihydrate ).,Oral liquid: 4 mg/5  mL (as hydrochloride dihydrate) .,Core
2,Medicines For Pain And Palliative Care,Dihydrate ).,senna  Oral liquid: 7.5 mg/5  mL.,Core
2,Medicines For Pain And Palliative Care,Oxygen * Inhalation,acetylsalicylic acid  Suppository:  50 mg to 150  mg.,Core
2,Medicines For Pain And Palliative Care,Oxygen * Inhalation,Tablet:  100 mg to 500  mg.,Core
2,Medicines For Pain And Palliative Care,Oxygen * Inhalation,"ibuprofen  a Oral liquid:  100 mg/5  mL [c], 200 mg/5  mL.",Core
2,Medicines For Pain And Palliative Care,Oxygen * Inhalation,Tablet:  200 mg; 400  mg; 600  mg.,Core
2,Medicines For Pain And Palliative Care,Oxygen * Inhalation,"paracetamol  (acetaminophen) * Oral liquid:  120 mg/5  mL or 125 mg/5  mL**, 250  mg/5  mL [c].",Core
2,Medicines For Pain And Palliative Care,Should Be Avoided.,"Suppository:  100 mg, 250  mg [c].",Core
2,Medicines For Pain And Palliative Care,Should Be Avoided.,"Tablet:  250 mg, 325  mg, 500 mg.",Core
2,Medicines For Pain And Palliative Care,Should Be Avoided.,"Tablet (dispersible):  100 mg, 250  mg [c].",Core
2,Medicines For Pain And Palliative Care,Sulfate).,Tablet (immediate release):  10 mg (morphine sulfate).,Core
2,Medicines For Pain And Palliative Care,Sulfate).,methadone*  Tablet: 5 mg; 10 mg (hydrochloride) .,Core
2,Medicines For Pain And Palliative Care,Sulfate).,Oral liquid:  5 mg/5 mL; 10 mg/5 mL (hydrochloride) .,Core
2,Medicines For Pain And Palliative Care,Sulfate).,amitriptyline  Oral liquid : 25 mg/5  mL [c].,Core
2,Medicines For Pain And Palliative Care,Sulfate).,Tablet: 10 mg; 25  mg; 75  mg.,Core
2,Medicines For Pain And Palliative Care,Sulfate).,cyclizine [c]  Injection: 50 mg/mL (lactate) .,Core
2,Medicines For Pain And Palliative Care,Sulfate).,Tablet:  50 mg (hydrochloride) .,Core
2,Medicines For Pain And Palliative Care,Sulfate).,dexamethasone  Injection: 4 mg/mL dexamethasone phosphate (as sodium phosphate),Core
2,Medicines For Pain And Palliative Care,Sulfate).,Oral liquid : 0.5 mg/5  mL [c]; 2 mg/5  mL (as sodium phosphate) .,Core
2,Medicines For Pain And Palliative Care,Sulfate).,Tablet : 0.5 mg; 0.75  mg; 1.5 mg; 2 mg; 4  mg (as dexamethasone,Core
2,Medicines For Pain And Palliative Care,To That Effect.,codeine  Tablet:  30 mg (phosphate).,Core
2,Medicines For Pain And Palliative Care,To That Effect.,- oxycodone  Granules ( slow release ; to mix with water):  20 mg; 30 mg; 60  mg;,Core
2,Medicines For Pain And Palliative Care,To That Effect.,Injection:  1 mg/mL  [c]; 2 mg/mL [c]; 10 mg/mL (morphine,Core
2,Medicines For Pain And Palliative Care,To That Effect.,Oral liquid:  5 mg/5mL [c]; 10 mg/5 mL (morphine hydrochloride or,Core
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,Therapeutic alternatives  to be reviewed  Injection:  10 mg/mL (besylate).,Core
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,neostigmine  Injection:  500 micrograms /mL (methylsulfate) in 1  mL ampoule;,Core
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,Tablet:  15 mg (bromide).,Core
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,suxamethonium  Injection:  50 mg/mL (chloride ) in 2 mL ampoule.,Core
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,-atracurium  Powder for injection:  10 mg (bromide) in vial.,Core
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,pyridostigmine  Injection:  5 mg/mL (bromide) in  ampoule  or vial .,Complementary
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,Tablet  (scored) : 60 mg (bromide).,Complementary
20,Muscle Relaxants (Peripherally -Acting) And Cholinesterase Inhibitors,Yellow Fever Vaccine,Therapeutic alternatives to be reviewed  Powder for injection:  10 mg (bromide) in vial.,Complementary
21,Ophthalmological Preparations,A > 3 Months.,epinephrine (adrenaline)  Solution (eye drops):  2% (as hydrochloride).,Complementary
21,Ophthalmological Preparations,A Not In Preterm Neonates.,acetazolamide  Tablet:  250 mg.,Core
21,Ophthalmological Preparations,A Not In Preterm Neonates.,latanoprost   Solution (eye drops):  50 micrograms /mL.,Core
21,Ophthalmological Preparations,A Not In Preterm Neonates.,- carbachol  Solution (eye drops):  2%; 4% (hydrochloride  or nitrate).,Core
21,Ophthalmological Preparations,A Not In Preterm Neonates.,agents) excluding combinations  Solution (eye drops):  0.25%; 0.5% (as hydrogen maleate).,Core
21,Ophthalmological Preparations,A Not In Preterm Neonates.,*EMLc only  Solution (eye drops):  0.1%; 0.5%; 1% (sulfate).,Core
21,Ophthalmological Preparations,Available.,oxytocin  Injection:  10 IU in 1 mL.,Complementary
21,Ophthalmological Preparations,Available.,mifepristone – misoprostol  Tablet  200 mg – tablet  200 micrograms.,Complementary
21,Ophthalmological Preparations,Bevacizumab*,*including quality -assured biosimilars  Injection: 25 mg/mL.,Complementary
21,Ophthalmological Preparations,Bevacizumab*,Therapeutic alternatives  to be reviewed   Tablet:  30 micrograms  + 150  micrograms .,Complementary
21,Ophthalmological Preparations,Bevacizumab*,Therapeutic alternatives  to be reviewed   Tablet:  35 micrograms  + 1 mg.,Complementary
21,Ophthalmological Preparations,Bevacizumab*,levonorgestrel  Tablet:  30 micrograms ; 750  micrograms  (pack of two); 1.5  mg.,Complementary
21,Ophthalmological Preparations,Bevacizumab*,ulipristal   Tablet: 30 mg (as acetate) .,Complementary
21,Ophthalmological Preparations,Equivalent (400  Micrograms ),tranexamic acid   Injection: 100 mg/mL in 10  mL ampoule .,Complementary
21,Ophthalmological Preparations,Equivalent (400  Micrograms ),caffeine citrate  [c] Injection: 20 mg/mL (equivalent to 10  mg caffeine base/mL).,Complementary
21,Ophthalmological Preparations,Equivalent (400  Micrograms ),Oral liquid:  20 mg/mL (equivalent to 10  mg caffeine base/mL).,Complementary
21,Ophthalmological Preparations,Equivalent (400  Micrograms ),chlorhexidine  [c] Solution or gel:  7.1% (digluconate) delivering 4% chlorhex idine (for,Complementary
21,Ophthalmological Preparations,Estradiol Cypionate + Medroxyprogesterone,acetate  Injection: 5 mg + 25 mg.,Complementary
21,Ophthalmological Preparations,Estradiol Cypionate + Medroxyprogesterone,medroxyprogesterone acetate  Injection (intramuscular):  150 mg/mL in 1 mL vial.,Complementary
21,Ophthalmological Preparations,Estradiol Cypionate + Medroxyprogesterone,Injection (subcutaneous):  104 mg/0.65  mL in pre -filled syringe or,Complementary
21,Ophthalmological Preparations,Etonogestrel.,ethinylestradiol + etonogestrel  Vaginal ring:  containing 2.7 mg + 11.7  mg.,Complementary
21,Ophthalmological Preparations,Gonorrhoea .,- tobramycin  Solution (eye drops): 0.3% (sulfate).,Core
21,Ophthalmological Preparations,Gonorrhoea .,Fluoroquinolones ) Solution (eye drops):  0.3%.,Core
21,Ophthalmological Preparations,Gonorrhoea .,Therapeutic alternatives  to be reviewed   Solution (eye drops):  0.5% (sodium phosphate).,Core
21,Ophthalmological Preparations,Gonorrhoea .,anaesthetics) excluding cocaine and combinations  Solution (eye drops):  0.5% (hydrochloride).,Core
21,Ophthalmological Preparations,Micronized Progesterone.,clomifene  Tablet:  50 mg (citrate).,Complementary
21,Ophthalmological Preparations,Micronized Progesterone.,carbetocin  Injection (heat stable): 100 micrograms /mL.,Complementary
21,Ophthalmological Preparations,Micronized Progesterone.,- methylergometrine  Injection:  200 micrograms  (hydrogen maleate) in 1  mL ampoule.,Complementary
21,Ophthalmological Preparations,Micronized Progesterone.,misoprostol  Tablet:  200 micrograms .,Complementary
21,Ophthalmological Preparations,Micronized Progesterone.,Vaginal tablet:  25 micrograms .*,Complementary
21,Ophthalmological Preparations,Tablet [4],misoprostol  Tablet:  200 micrograms.,Complementary
21,Ophthalmological Preparations,Tablet [4],dexamethasone  Injection: 4 mg/mL dexamethasone phosphate (as sodium,Complementary
21,Ophthalmological Preparations,Tablet [4],WHO Model List of Essential Medicines – 24th List (2025 ) page 56 multiple micronutrient supplement * Tablet  containing :,Complementary
21,Ophthalmological Preparations,Umbilical Cord Care).,- dinoprostone (prostaglandin E2)  Solution for injection: 0.5 mg/mL in alcohol.,Complementary
21,Ophthalmological Preparations,Umbilical Cord Care).,- indometacin  Solution for injection : 5 mg/mL.,Complementary
21,Ophthalmological Preparations,Yellow Fever Vaccine,azithromycin  Solution (eye drops): 1.5%.,Core
23,Peritoneal Dialysis Solution,Clinical Guidelines .,- zuclopenthixol decanoate  Injection:  25 mg (decanoate  or enantate) in 1  mL ampoule.,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,- chlorpromazine  Tablet:  2 mg; 5 mg.,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,haloperidol  Injection:  5 mg/mL in 1 mL ampoule.,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,olanzapine  Powder for injection : 10 mg in vial .,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,- risperidone injection  Injection (prolonged -release) : 25 mg; 50 mg; 75 mg; 100 mg;,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,amitriptyline  Tablet:  25 mg; 75 mg (hydrochloride).,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,carbamazepine  Tablet (scored):  100 mg; 200  mg; 400 mg.,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,Tablet (immediate -release): 25 mg; 100 mg; 150 mg; 200 mg;,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,Tablet (modified -release): 50 mg; 150 mg; 200 mg; 300 mg;,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,valproate) in the womb.  Tablet (enteric -coated): 200 mg; 500  mg.,Complementary
23,Peritoneal Dialysis Solution,Clinical Guidelines .,- lorazepam   Tablet (scored):  2 mg; 5 mg.,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,clomipramine  Capsule:  10 mg; 25 mg (hydrochloride).,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,acamprosate  calcium  Tablet: 333 mg.,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,naltrexone  Injection suspension (extended -release): 380 mg in vial .,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,Tablet: 50 mg.,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,bupropion   Tablet  (sustained -release) : 150 mg (hydrochloride) .,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,cytisine (cytisinicline)  Tablet: 1.5 mg.,Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,"varenicline  Tablet: 0.5 mg, 1 mg.",Complementary
23,Peritoneal Dialysis Solution,Symptoms Only,Oral liquid: 5 mg/5 mL; 10 mg/5 mL (hydrochloride).,Complementary
23,Peritoneal Dialysis Solution,Umbilical Cord Care).,intraperitoneal dialysis solution  Solution : of appropriate composition  in accordance with local,Complementary
25,Medicines Acting On The Respiratory Tract,Ampoule.,ipratropium bromide  Solution for inhalation : 20 micrograms  per actuation  in,Core
25,Medicines Acting On The Respiratory Tract,Ampoules For Use In Nebulizers;,- umeclidinium  Powder for inhalaton: 18 micrograms  in capsule .,Core
25,Medicines Acting On The Respiratory Tract,Ampoules For Use In Nebulizers;,Solution for inhalation : 1.25 micrograms ; 2.5 micrograms  per,Core
25,Medicines Acting On The Respiratory Tract,Inhaler .,- mometasone + formoterol  Powder for inhalation : 100 micrograms  + 6 micrograms  per,Core
25,Medicines Acting On The Respiratory Tract,Powder Inhaler .,epinephrine (adrenaline)  Injection:  1 mg/mL (as hydrochloride or hydrogen  tartrate) in 1  mL,Core
25,Medicines Acting On The Respiratory Tract,Pressurized Metered -Dose Inhaler .,"Injection:  500 micrograms /mL (as sulfate) in 1 mL, 5 mL ampoule.",Core
25,Medicines Acting On The Respiratory Tract,Pressurized Metered -Dose Inhaler .,Solution for inhalation :,Core
25,Medicines Acting On The Respiratory Tract,Programme.,- mometasone  Powder for inhalation: 100 micrograms per actuation;,Core
26,"Solutions Correcting Water, Electrolyte And Acid –Base Disturbances",Potassium Chloride  Powder For Solution.,potassium chloride  Solution:  11.2% in 20  mL ampoule,Core
26,"Solutions Correcting Water, Electrolyte And Acid –Base Disturbances",Potassium Chloride  Powder For Solution.,Solution for dilution: 7.5% (equivalent to K+ 1 mmol/ mL and Cl–,Core
26,"Solutions Correcting Water, Electrolyte And Acid –Base Disturbances",Potassium Chloride  Powder For Solution.,"Solution : 8.4% in 10  mL ampoule (equivalent to Na+ 1000  mmol/L,",Core
27,Vitamins And Minerals,Ampoule  Or Vial .,riboflavin  Tablet:  5 mg.,Core
27,Vitamins And Minerals,Ampoule  Or Vial .,thiamine  Injection: 50 mg/mL (hydrochloride) in ampoule or vial [c].,Core
27,Vitamins And Minerals,Ampoule  Or Vial .,Tablet:  50 mg (hydrochloride).,Core
27,Vitamins And Minerals,Ampoule  Or Vial .,calcium gluconate  Injection:  100 mg/mL in 10  mL ampoule.,Complementary
27,Vitamins And Minerals,Palmitate).,Oral liquid : 100 000 IU/mL (as palmitate ).,Core
27,Vitamins And Minerals,Potassium Chloride  Powder For Solution.,ascorbic acid  Tablet:  50 mg.,Core
27,Vitamins And Minerals,Potassium Chloride  Powder For Solution.,calcium  Tablet:  500 mg (elemental).,Core
27,Vitamins And Minerals,Potassium Chloride  Powder For Solution.,- ergocalciferol  Oral liquid:  400 IU/mL.,Core
27,Vitamins And Minerals,Potassium Chloride  Powder For Solution.,Oral liquid:  250 micrograms /mL (10 000 IU/mL).,Core
27,Vitamins And Minerals,Values,nicotinamide  Tablet:  50 mg.,Core
27,Vitamins And Minerals,Values,pyridoxine  Tablet:  10 mg [c]; 25 mg (hydrochloride).,Core
28,"Ear, Nose And Throat Medicines",Ampoule  Or Vial .,acetic acid  [c] Solution (ear drops) : 2%.,Core
28,"Ear, Nose And Throat Medicines",Ampoule  Or Vial .,- ofloxacin  Solution (ear drops) : 0.3% (as hydrochloride).,Core
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,allopurinol  Tablet:  100 mg.,Core
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,chloroquine  Tablet:  100 mg; 150  mg (as phosphate  or sulfate).,Core
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,azathioprine  Tablet:  50 mg.,Complementary
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,methotrexate  Tablet:  2.5 mg (as sodium).,Complementary
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,sulfasalazine  Tablet:  500 mg.,Complementary
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,acetylsalicylic acid * Suppository: 150 mg; 300 mg.,Complementary
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,Tablet: 75 mg to 500  mg.,Complementary
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,Tablet (dispersible):  75 mg; 300 mg; 500 mg.,Complementary
29,Medicines For Diseases Of Joints,Ampoule  Or Vial .,*including quality -assured biosimilars  Injection:  10 mg/0.2  mL [c]; 20 mg/0.2 mL [c]; 20 mg/0 .4 mL [c];,Complementary
29,Medicines For Diseases Of Joints,Or Pre -Filled Pen.,methotrexate  Tablet:  2.5 mg (as sodium).,Complementary
29,Medicines For Diseases Of Joints,Or Pre -Filled Pen.,- triamcinolone acetonide  Injection: 20 mg/mL in vial .,Complementary
3,Antiallergics And Medicines Used In Anaphylaxis,Ampoule.,hydrocortisone  Powder for injection:  100 mg (as sodium succinate) in vial.,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Ampoule.,- fexofenadine  Oral liquid: 1 mg/mL.,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Ampoule.,Tablet: 10 mg.,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Ampoule.,Tablet (chewable):  5 mg [c]; 10 mg [c].,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Ampoule.,- prednisone  Oral liquid:  5 mg/mL [c].,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Ampoule.,Tablet:  5 mg; 25  mg.,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Base).,epinephrine (adrenaline)  Injection:  1 mg/mL (as hydrochloride or hydrogen  tartrate) in 1  mL,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Dihydrate ).,dexamethasone  Injection: 4 mg/mL dexamethasone phosphate (as sodium phosphate),Core
3,Antiallergics And Medicines Used In Anaphylaxis,Dihydrate ).,Oral liquid:  0.5 mg/5  mL[c]; 2 mg/5  mL (as sodium phosphate).,Core
3,Antiallergics And Medicines Used In Anaphylaxis,Dihydrate ).,Tablet:  0.5 mg; 0.75  mg; 1.5  mg; 2  mg; 4  mg (as dexamethasone,Core
30,Dental Medicines And Preparations,Administration E.G. Gargles And Mouthwashes.,Oral liquids presented as powders or granules may offer benefits in the,Core
30,Dental Medicines And Preparations,Administration E.G. Gargles And Mouthwashes.,"Injection  Refers to solutions, suspensions and emulsions including those constituted",Core
30,Dental Medicines And Preparations,Any Type Of Modified -Release Granules.,"Oral liquid  Liquid preparations intended to be swallowed  i.e. oral solutions,",Core
30,Dental Medicines And Preparations,From Powders Or Concentrated Solutions.,Injection (qualified)  Route of administration is indicated in parentheses where relevant.,Core
30,Dental Medicines And Preparations,From Powders Or Concentrated Solutions.,Injection (oily)  The term `injection’ is qualified by `(oily)’ in relevant entries.,Core
30,Dental Medicines And Preparations,Modified -Release Tablet.,Tablets  Refers to:,Core
30,Dental Medicines And Preparations,Modified -Release Tablet.,Tablets (qualified)  Refers to a specific type of tablet:,Core
30,Dental Medicines And Preparations,Of Modified -Release Capsule.,Capsules (qualified)  The term 'capsule' with qualification refers to gastro -resistant  (such,Core
30,Dental Medicines And Preparations,Of Modified -Release Capsule.,Granules  Preparations that are issued to patient as granules to be swallowed without,Core
30,Dental Medicines And Preparations,Or Concentrated Solutions.,Vaginal  Pessaries or vaginal tablets.,Core
30,Dental Medicines And Preparations,Or Concentrated Solutions.,"Inhalation  Powder for inhalation, solution for inhalation, suspension for inhalation .",Core
30,Dental Medicines And Preparations,Or Pre -Filled Pen.,"Powder (fluoro -alumino -silicate glass) contains: 25 -50% silicate, 20 -40%",Core
30,Dental Medicines And Preparations,Or Pre -Filled Pen.,silver diamine fl uoride Solution: 38% w/v .,Core
30,Dental Medicines And Preparations,Swallowed;,WHO Model List of Essential Medicines – 24th List (2025 ) page 64 Capsules  Refers to hard or soft capsules.,Core
4,Antidotes And Other Substances Used In Poisonings,Ampoule .,fomepizole  Injection: 5 mg/mL (sulfate) in 20  mL ampoule or 1  g/mL (base) in,Complementary
4,Antidotes And Other Substances Used In Poisonings,Ampoule .,sodium calcium edetate   Injection:  200 mg/mL in 5 mL ampoule.,Complementary
4,Antidotes And Other Substances Used In Poisonings,Ampoule.,"charcoal, activated  Granules for oral suspension *: 50 mg.",Core
4,Antidotes And Other Substances Used In Poisonings,Available .,acetylcysteine  Injection:  200 mg/mL in 10  mL ampoule.,Core
4,Antidotes And Other Substances Used In Poisonings,Available .,atropine  Injection:  1 mg/mL (sulfate) in 1  mL ampoule  or vial .,Core
4,Antidotes And Other Substances Used In Poisonings,Available .,calcium gluconate  Injection:  100 mg/mL (10%) in 10  mL ampoule  or vial .,Core
4,Antidotes And Other Substances Used In Poisonings,Methylthioninium Chloride,(methylene blue)  Injection:  10 mg/mL in 10  mL ampoule.,Core
4,Antidotes And Other Substances Used In Poisonings,Methylthioninium Chloride,naloxone  Injection:  400 micrograms (hydrochloride) in 1  mL ampoule.,Core
4,Antidotes And Other Substances Used In Poisonings,Potassium Ferric Hexacyano -Ferrate(Ii) -2H 2O,(Prussian blue)  Powder for oral administration.,Core
4,Antidotes And Other Substances Used In Poisonings,Potassium Ferric Hexacyano -Ferrate(Ii) -2H 2O,sodium nitrite  Injection:  30 mg/mL in 10  mL ampoule.,Core
4,Antidotes And Other Substances Used In Poisonings,Potassium Ferric Hexacyano -Ferrate(Ii) -2H 2O,sodium thiosulfate  Injection:  250 mg/mL in 50  mL ampoule.,Core
4,Antidotes And Other Substances Used In Poisonings,Potassium Ferric Hexacyano -Ferrate(Ii) -2H 2O,deferoxamine  Powder for injection:  500 mg (mesilate) in vial.,Complementary
4,Antidotes And Other Substances Used In Poisonings,Potassium Ferric Hexacyano -Ferrate(Ii) -2H 2O,dimercaprol  Injection in oil:  50 mg/mL in 2 mL ampoule ; 100 mg/mL in 3  mL,Complementary
5,Medicines For Neurological Disorders,A > 25 Kg.,- tinidazole  Injection:  500 mg in 100  mL vial.,Complementary
5,Medicines For Neurological Disorders,A > 25 Kg.,Oral liquid:  200 mg/5  mL (as benzoate) .,Complementary
5,Medicines For Neurological Disorders,A > 25 Kg.,Tablet:  200 mg; 250  mg; 400  mg; 500 mg.,Complementary
5,Medicines For Neurological Disorders,A > 25 Kg.,amphotericin B * Powder for injection:  50 mg (liposomal complex)  in vial.,Complementary
5,Medicines For Neurological Disorders,A > 25 Kg.,Powder for injection: 50 mg (as sodium deoxycholate) in vial .,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,- valaciclovir (oral)  Oral liquid:  200 mg/5 mL [c].,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Powder for solution for infusion:  250 mg (as sodium dihydrate) in vial.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Solution for infusion : 25 mg/mL (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet:  200 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,neostigmine  Injection:  500 micrograms/mL (methylsulfate) in 1  mL ampoule;,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet:  15 mg (bromide).,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,pyridostigmine  Injection:  5 mg/mL (bromide) in ampoule or vial.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet (scored):  60 mg (bromide).,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,"albendazole  Tablet (chewable , scored ): 400 mg.",Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,ivermectin  Tablet:  3 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,levamisole  Tablet:  50 mg; 150  mg (as hydrochloride).,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,mebendazole  Tablet (chewable):  100 mg; 500  mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,niclosamide  Tablet (chewable):  500 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,"praziquantel  Tablet:  150 mg, 500  mg.",Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet  (scored):  600 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,pyrantel  Tablet (chewable):  250 mg (as embonate or  pamoate).,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,diethylcarbamazine  Tablet:  50 mg; 100  mg (dihydrogen citrate).,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,- moxidectin  Tablet : 3 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,- arpraziquantel (Tablet (dispersible): 150 mg) [c],Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,praziquantel on the EMLc for schistosomiasis  Tablet:  150 mg; 500 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,triclabendazole  Tablet  (scored) : 250 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,oxamniquine * Capsule:  250 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Oral liquid:  250 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,albendazole  Tablet (chewable): 200 mg [c].,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,"Tablet (chewable , scored ): 400 mg.",Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,"mebendazole  Tablet (chewable):  100 mg [c], 500 mg.",Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,"praziquantel  Tablet:  150 mg, 500 mg.",Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet (scored):  600 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,amikacin  Injection:  50 mg/mL (as sulfate)  [c]; 250 mg/mL (as sulfate)  in 2 mL vial.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,vancomycin  Powder for injection:  250 mg; 500  mg; 1  g (as hydrochloride) in vial.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,cefiderocol  Powder for injection: 1 g (as sulfate toxylate)  in vial.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,ceftazidime + avibactam  Powder for injection: 2 g + 0.5  g in vial .,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,ceftolozane + tazobactam  Powder for injection: 1 g + 0.5  g in vial .,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,colistin   Powder for injection: 1 million  IU (as colistemethate sodium)  (equivalent to,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,fosfomycin  Powder for injection:  2 g; 4 g (as sodium) in vial .,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,- tedizolid phosphate  Injection for intravenous administration:  2 mg/mL in 300  mL bag.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Powder for oral liquid : 100 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet:  600 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,Tablet (dispersible):  150 mg [c].,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,WHO Model List of Essential Medicines – 24th List (2025 ) page 18 meropenem + vaborbactam  Powder for injection: 1 g (as trihydrate)  + 1 g in vial .,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,plazomicin  Injection : 500  mg/10  mL.,Complementary
5,Medicines For Neurological Disorders,A > 3 Months.,polymyxin B  Powder for injection: 500 000 IU (equivalent to 50  mg polymyxin B base) in,Complementary
5,Medicines For Neurological Disorders,A > 3 Years,Tablet (heat stable):  100 mg + 25  mg; 200  mg + 50 mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Years,ritonavir  Tablet (heat stable): 25 mg; 100  mg.,Complementary
5,Medicines For Neurological Disorders,A > 3 Years,"dolutegravir a  Tablet (dispersible , scored ): 10 mg [c].",Complementary
5,Medicines For Neurological Disorders,A > 3 Years,Tablet : 50 mg,Complementary
5,Medicines For Neurological Disorders,A > 6 Weeks,atazanavir + ritonavir   Tablet (heat stable): 300 mg (as sulfate) + 100  mg.,Complementary
5,Medicines For Neurological Disorders,A > 6 Weeks,darunavir  a Tablet:  75 mg; 400  mg; 600  mg; 800  mg,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,mefloquine  Tablet  (scored) : 250 mg (as hydrochloride).,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,pyrimethamine  Tablet:  25 mg.,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,sulfadiazine  Tablet: 500 mg.,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,sulfamethoxazole + trimethoprim  Injection: 80 mg + 16  mg/mL in 5 mL ampoule; 80  mg +,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,Oral liquid:  200 mg + 40  mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,Tablet:  100 mg + 20  mg [c]; 400 mg + 80  mg [c]; 800  mg +,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,Tablet (dispersible):  100 mg + 20  mg [c].,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,pentamidine  Tablet:  200 mg; 300  mg (as isethionate).,Complementary
5,Medicines For Neurological Disorders,A > 8 Years,fexinidazole * Tablet: 600 mg,Complementary
5,Medicines For Neurological Disorders,A ≥ 25 Kg,WHO Model List of Essential Medicines – 24th List (2025 ) page 22 raltegravir * Granules for oral suspension : 100  mg in sachet.,Complementary
5,Medicines For Neurological Disorders,A ≥ 25 Kg,Tablet (chewable): 25 mg.,Complementary
5,Medicines For Neurological Disorders,A ≥ 25 Kg,Tablet:  400 mg.,Complementary
5,Medicines For Neurological Disorders,Adults.,WHO Model List of Essential Medicines – 24th List (2025 ) page 17 piperacillin + tazobactam  Powder for injection: 2 g (as sodium) + 250  mg (as sodium); 4  g (as sodium) + 500  mg,Complementary
5,Medicines For Neurological Disorders,Adults.,vancomycin*  Capsule:  125 mg; 250  mg (as hydrochloride).,Complementary
5,Medicines For Neurological Disorders,Adults.,ceftazidime  Powder for injection: 250 mg; 1 g (as pentahydrate) in vial.,Complementary
5,Medicines For Neurological Disorders,Amoxicillin,Powder for injection : 250  mg; 500  mg; 1  g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Amoxicillin,Powder for oral liquid:  125 mg/5  mL; 250  mg/5  mL (as trihydrate)  [c].,Complementary
5,Medicines For Neurological Disorders,Amoxicillin,"Tablet (dispersible, scored): 250 mg; 500 mg (as trihydrate)  [c].",Complementary
5,Medicines For Neurological Disorders,Amoxicillin + Clavulanic Acid,Powder for injection:  500 mg (as sodium) + 100  mg (as potassium salt); 1000  mg (as,Complementary
5,Medicines For Neurological Disorders,Amoxicillin + Clavulanic Acid,Powder for o ral liquid:  125 mg (as trihydrate)  + 31.25  mg (as potassium salt) /5 mL;,Complementary
5,Medicines For Neurological Disorders,Amoxicillin + Clavulanic Acid,Tablet:  500 mg (as trihydrate) + 125  mg (as potassium salt) ; 875  mg (as trihydrate),Complementary
5,Medicines For Neurological Disorders,Amoxicillin + Clavulanic Acid,Tablet (dispersible):  200 mg (as trihydrate) + 28.5 mg (as potassium salt)  [c];,Complementary
5,Medicines For Neurological Disorders,Ampoule .,carbamazepine  Oral liquid:  100 mg/5  mL.,Core
5,Medicines For Neurological Disorders,Ampoule .,Tablet (chewable):  100 mg; 200  mg.,Core
5,Medicines For Neurological Disorders,Ampoule .,Tablet (scored):  100 mg; 200  mg; 400 mg.,Core
5,Medicines For Neurological Disorders,Ampoule .,lamotrigine * Tablet : 25 mg; 50  mg; 100  mg; 200  mg.,Core
5,Medicines For Neurological Disorders,Ampoule .,"Tablet (chewable, dispersible):  2 mg; 5  mg; 25  mg; 50  mg; 100  mg;",Core
5,Medicines For Neurological Disorders,Ampoule.,Oral liquid:  200 mg + 40  mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Ampoule.,Tablet:  100 mg + 20  mg; 400  mg + 80  mg; 800  mg + 160  mg.,Complementary
5,Medicines For Neurological Disorders,Ampoule.,Tablet (dispersible):  100 mg + 20  mg [c].,Complementary
5,Medicines For Neurological Disorders,Aspergillosis.,- caspofungin  Powder for injection: 50 mg (as sodium) ; 100  mg (as sodium) in vial .,Complementary
5,Medicines For Neurological Disorders,At National Level.,daclatasvir * Tablet:  30 mg; 60 mg (as dihydrochloride) .,Complementary
5,Medicines For Neurological Disorders,At National Level.,daclatasvir + sofosbuvir   Tablet : 60 mg (as dihydrochloride) + 400  mg.,Complementary
5,Medicines For Neurological Disorders,At National Level.,glecaprevir + pibrentasvir  Granules : 50 mg + 20  mg in sachet [c].,Complementary
5,Medicines For Neurological Disorders,At National Level.,Tablet: 100 mg + 40  mg.,Complementary
5,Medicines For Neurological Disorders,At National Level.,ravidasvir * Tablet: 200 mg.,Complementary
5,Medicines For Neurological Disorders,At National Level.,sofosbuvir *  Granules: 200 mg in sachet [c].,Complementary
5,Medicines For Neurological Disorders,At National Level.,Tablet:  200 mg; 400 mg.,Complementary
5,Medicines For Neurological Disorders,At National Level.,sofosb uvir + velpatasvir  Granules: 150 mg + 37.5  mg; 200  mg + 50  mg in sachet [c].,Complementary
5,Medicines For Neurological Disorders,At National Level.,Tablet: 200 mg + 50 mg [c]; 400 mg + 100  mg.,Complementary
5,Medicines For Neurological Disorders,At National Level.,ledipasvir + sofosbuvir   Tablet:  90 mg + 400  mg.,Complementary
5,Medicines For Neurological Disorders,At National Level.,ribavirin * Injection for intravenous administration: 800 mg; 1 g in 10  mL,Complementary
5,Medicines For Neurological Disorders,Available .,"phenobarbital   Injection: 30 mg/mL  or 60 mg/mL  [c], 200 mg/mL (sodium).",Core
5,Medicines For Neurological Disorders,Available .,Oral liquid:  15 mg/5  mL.,Core
5,Medicines For Neurological Disorders,Available .,Tablet:  15 mg; 30 mg; 60  mg; 100 mg.,Core
5,Medicines For Neurological Disorders,Available .,WHO Model List of Essential Medicines – 24th List (2025 ) page 6 phenytoin  Injection:  50 mg/mL (phenytoin sodium) .,Core
5,Medicines For Neurological Disorders,Available .,Oral liquid:  30 mg/5  mL (phenytoin) .,Core
5,Medicines For Neurological Disorders,Available .,Tablet (chewable): 50 mg (phenytoin) .,Core
5,Medicines For Neurological Disorders,Available .,prednisolone  [c] Oral liquid: 1 mg/mL.,Core
5,Medicines For Neurological Disorders,Available .,Tablet: 1 mg; 5  mg; 10  mg.,Core
5,Medicines For Neurological Disorders,Avoided.,Suppository:  250 mg [c].,Complementary
5,Medicines For Neurological Disorders,Avoided.,Tablet:  250 mg; 325  mg; 500  mg.,Complementary
5,Medicines For Neurological Disorders,Avoided.,"Tablet (dispersible):  100 mg, 250  mg [c].",Complementary
5,Medicines For Neurological Disorders,Avoided.,Tablet:  50 mg.,Complementary
5,Medicines For Neurological Disorders,Avoided.,propranolol   Tablet:  10 mg [c]; 40 mg (hydrochloride).,Complementary
5,Medicines For Neurological Disorders,Avoided.,prednisolone  Tablet: 5 mg; 25  mg.,Complementary
5,Medicines For Neurological Disorders,Avoided.,sumatriptan  Injection (subcutaneous): 6 mg/ 0.5  mL in pre -filled syringe or pen.,Complementary
5,Medicines For Neurological Disorders,Avoided.,verapamil  Tablet (immediate -release): 40 mg; 80  mg; 120  mg.,Complementary
5,Medicines For Neurological Disorders,Avoided.,Tablet (extended -release):  120 mg; 180  mg; 240  mg.,Complementary
5,Medicines For Neurological Disorders,Avoided.,amoxicillin  Powder for injection : 250 mg; 500 mg; 1 g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Avoided.,Powder for oral liquid:  125 mg/5 mL; 250 mg/5 mL (as trihydrate)  [c].,Complementary
5,Medicines For Neurological Disorders,Avoided.,"Tablet (dispersible, scored): 250 mg; 500 mg (as trihydrate)  [c].",Complementary
5,Medicines For Neurological Disorders,Avoided.,ampicillin  Powder for injection:  500 mg; 1 g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Avoided.,benzylpenicillin  Powder for injection:  600 mg (= 1 million IU); 3 g (= 5 million IU) (sodium  or potassium,Complementary
5,Medicines For Neurological Disorders,Bioavailability.,doxycycline  a Oral liquid: 50 mg/5  mL (calcium ) [c].,Complementary
5,Medicines For Neurological Disorders,Bioavailability.,Powder for oral liquid: 25 mg/5  mL (monohydrate)  [c].,Complementary
5,Medicines For Neurological Disorders,Bioavailability.,Powder for injection : 100  mg in vial .,Complementary
5,Medicines For Neurological Disorders,Bioavailability.,Tablet (dispersible):  100 mg (as monohydrate) [c].,Complementary
5,Medicines For Neurological Disorders,Critically Ill Hospitalized Patients,valganciclovir *[c] Powder for oral solution: 50 mg/mL  (as hydrochloride).,Complementary
5,Medicines For Neurological Disorders,Critically Ill Hospitalized Patients,Tablet:  450 mg (as hydrochloride) .,Complementary
5,Medicines For Neurological Disorders,Critically Ill Hospitalized Patients,entecavir  Oral liquid:  0.05 mg/mL,Complementary
5,Medicines For Neurological Disorders,Critically Ill Hospitalized Patients,Tablet:  0.5 mg; 1  mg,Complementary
5,Medicines For Neurological Disorders,Critically Ill Hospitalized Patients,tenofovir disoproxil fumarate  Tablet: 300 mg (tenofovir disoproxil fumarate – equivalent to,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,clotrimazole  Vaginal cream:  1%; 10%.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Vaginal tablet:  100 mg; 500  mg.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,fluconazole  Capsule:  50 mg.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Injection:  2 mg/mL in vial.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Oral liquid:  50 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Powder for oral liquid:  50 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,flucytosine  Capsule:  250 mg.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Infusion:  2.5 g in 250  mL.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,WHO Model List of Essential Medicines – 24th List (2025 ) page 20 griseofulvin  Oral liquid: 125 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,itraconazole*  Capsule : 100 mg.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Oral liquid:  10 mg/mL.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Oral liquid:  100 000 IU/mL [c].,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,voriconazole*  Tablet: 50 mg; 200  mg,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Powder for injection: 200 mg in vial,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Powder for oral liquid: 40 mg/mL,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,meglumine antimoniate  Injection: 1.5 g/5 mL in 5  mL ampoule .,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,paromomycin  Solution for intramuscular injection: 750 mg of paromomycin base,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,sodium stibogluconate   Injection:  100 mg/mL in 30 mL vial.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,artemether + lumefantrine  Tablet:  20 mg + 120  mg.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,Tablet (dispersible):  20 mg + 120  mg [c].,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,artesunate  Powder for injection: 30 mg; 60 mg; 120 mg in vial .,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,artesunate + amodiaquine  Tablet:  25 mg +  67.5 mg; 50  mg +  135 mg; 100  mg + 270  mg.,Complementary
5,Medicines For Neurological Disorders,Depending On Local Availability And Cost.,artesunate + mefloquine  Tablet:  25 mg +  50 mg (as hydrochloride) ; 100  mg +  200 mg (as,Complementary
5,Medicines For Neurological Disorders,Diloxanide * A,*proposed for deletion in 2027  Tablet : 500 mg (furoate).,Complementary
5,Medicines For Neurological Disorders,Disorders.,"midazolam  Solution for oromucosal administration:  5 mg/mL  in 0.5 mL, 1 mL,",Core
5,Medicines For Neurological Disorders,Disorders.,Injection *: 1 mg/mL  in 5 mL vial; 5 mg/mL in 1  mL or 3 mL vial.,Core
5,Medicines For Neurological Disorders,Dysentery,WHO Model List of Essential Medicines – 24th List (2025 ) page 15 trimethoprim  Tablet: 100 mg; 200  mg.,Complementary
5,Medicines For Neurological Disorders,Dysentery,Oral liquid:  50 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Dysentery,Powder for o ral liquid:  200 mg/5  mL (anhydrous)  [c].,Complementary
5,Medicines For Neurological Disorders,Dysentery,cefixime  Powder for oral liquid:  100 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Dysentery,cefotaxime *  Powder for injection: 250 mg; 500 mg; 1 g; 2 g (as sodium)  in vial.,Complementary
5,Medicines For Neurological Disorders,Efavirenz +  Emtricitabine + Tenofovir,- lamivudine  (for emtricitabine ) Tablet: 600 mg + 200  mg + 300  mg (tenofovir disoproxil fumarate,Complementary
5,Medicines For Neurological Disorders,Efavirenz +  Emtricitabine + Tenofovir,efavirenz + lamivudine + tenofovir  Tablet : 400 mg + 300  mg + 300  mg (tenofovir disoproxil fumarate,Complementary
5,Medicines For Neurological Disorders,Efavirenz +  Emtricitabine + Tenofovir,- lamivudine (for emtricitabine)  Tablet:  200 mg + 300  mg (tenofovir disoproxil fumarate  –,Complementary
5,Medicines For Neurological Disorders,Efavirenz +  Emtricitabine + Tenofovir,lamivudine + zidovudine  Tablet:  30 mg + 60  mg [c]; 150  mg + 300  mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,rifampicin  Tablet:  275 mg + 75  mg + 400  mg + 150  mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,ethambutol + isoniazid + rifampicin  Tablet: 275 mg + 75  mg + 150 mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,*for multidrug -resistant tuberculosis  Tablet:  250 mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,Tablet (dispersible ): 125  mg [c].,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,isoniazid  Tablet:  100 mg; 300 mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,"Tablet (dispersible , scored ): 100 mg [c].",Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,WHO Model List of Essential Medicines – 24th List (2025 ) page 19 isoniazid + pyrazinamide + rifampicin   Tablet (dispersible): 50 mg + 150  mg + 75  mg [c].,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,isoniazid + rifampicin  Tablet:  75 mg + 150  mg; 150  mg + 300  mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,Tablet (dispersible): 50 mg + 75  mg [c].,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,isoniazid  + rifapentine  Tablet (scored): 300 mg + 300  mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,levofloxacin  Tablet:  250 mg; 500  mg; 750  mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,Tablet (dispersible ): 100  mg [c].,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,linezolid  Tablet: 600 mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,"Tablet (dispersible , scored ): 150 mg [c].",Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,- imipenem + cilastatin  Powder for injection: 500 mg (as trihydrate); 1  g (as trihydrate) in vial.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,moxifloxacin  Tablet: 400 mg.,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,Tablet (dispersible):  100 mg [c].,Complementary
5,Medicines For Neurological Disorders,Ethambutol + Isoniazid + Pyrazinamide +,p-aminosalicylate sodium  Powder for oral solution : 5.52  g in sachet (equivalent to 4  g,Complementary
5,Medicines For Neurological Disorders,Exposed To Valproic Acid (Sodium,"valproate) in the womb.  Injection:  100 mg/mL in 3 mL, 4 mL, 10 mL ampoule.",Complementary
5,Medicines For Neurological Disorders,Exposed To Valproic Acid (Sodium,cladribine  Tablet: 10 mg.,Complementary
5,Medicines For Neurological Disorders,Exposed To Valproic Acid (Sodium,glatiramer acetate  Injection (subcutaneous): 20 mg/mL ; 40 mg/mL in pre-filled syringe.,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,artesunate + pyronaridine  Granules : 20 mg + 60  mg (tetraphosphate)  [c].,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,Tablet: 60 mg + 180  mg (tetraphosphate) .,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,chloroquine  Oral liquid:  50 mg/5  mL (base ).,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,Tablet:  150 mg (base ).,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,dihydroartemisinin + piperaquine   Tablet: 20 mg + 160  mg (phosphate) ; 40 mg + 320  mg,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,Tablet (dispersible):  20 mg + 160  mg (phosphate); 40  mg +,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,primaquine * Tablet:  7.5 mg; 15  mg (as phosphate).,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,WHO Model List of Essential Medicines – 24th List (2025 ) page 25 quinine  Solution for infusion : 60 mg/mL [c]; 300 mg/mL (hydrochloride) in,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,sulfadoxine + pyrimethamine  Tablet  (dispersible) : 250 mg + 12.5 mg [c]; 500 mg + 25  mg.,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,doxycycline  a Oral liquid: 50 mg/5  mL (calcium).,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,Powder for oral liquid: 25 mg/5  mL (monohydrate).,Complementary
5,Medicines For Neurological Disorders,Hydrochloride) .,Tablet (dispersible): 100 mg (as monohydrate).,Complementary
5,Medicines For Neurological Disorders,In Adults.,Powder for injection:  1 g (as sodium succinate) in vial.,Complementary
5,Medicines For Neurological Disorders,In Adults.,WHO Model List of Essential Medicines – 24th List (2025 ) page 13 clindamycin  Capsule:  150 mg (as hydrochloride).,Complementary
5,Medicines For Neurological Disorders,In Adults.,Injection:  150 mg/mL  (as phosphate) ; 600 mg/4  mL (as phosphate) ; 900 mg/6 mL,Complementary
5,Medicines For Neurological Disorders,In Adults.,Powder for o ral liquid: 75 mg/5  mL (as palmitate  hydrochloride ) [c].,Complementary
5,Medicines For Neurological Disorders,In Adults.,"penicillins)  Capsule:  250 mg [c], 500 mg; 1  g (as sodium).",Complementary
5,Medicines For Neurological Disorders,In Adults.,"Powder for injection:  250 mg [c], 500 mg (as sodium) in vial.",Complementary
5,Medicines For Neurological Disorders,In Adults.,"Powder for oral liquid:  125 mg/5  mL, 250  mg/5  mL (as sodium)  [c].",Complementary
5,Medicines For Neurological Disorders,Infection.,suramin sodium * Powder for injection:  1 g in vial.,Complementary
5,Medicines For Neurological Disorders,Infection.,melarsoprol  Injection:  180 mg/5  mL in 5 mL ampoule ( 3.6% solution ).,Complementary
5,Medicines For Neurological Disorders,Infection.,nifurtimox * Tablet  (scored) : 30 mg; 120 mg.,Complementary
5,Medicines For Neurological Disorders,Infection.,melarsoprol  [c] Injection:  180 mg/5  mL in 5 mL ampoule (3.6% solution).,Complementary
5,Medicines For Neurological Disorders,Infection.,benznidazole  Tablet:  12.5 mg [c],Complementary
5,Medicines For Neurological Disorders,Infection.,Tablet (scored):  50 mg; 100 mg.,Complementary
5,Medicines For Neurological Disorders,Infection.,nifurtimox  Tablet  (scored) : 30 mg; 120  mg.,Complementary
5,Medicines For Neurological Disorders,Infection.,ivermectin  Tablet: 3 mg.,Complementary
5,Medicines For Neurological Disorders,Infection.,ansuvimab  Powder for injection: 400 mg.,Complementary
5,Medicines For Neurological Disorders,Infection.,atoltivimab + maftivimab + odesivimab  Injection:  241.7  mg + 241.7  mg + 241.7  mg in 14.5  mL vial.,Complementary
5,Medicines For Neurological Disorders,Infections (Severe),nitrofurantoin  Oral liquid:  25 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Infections (Severe),phenoxymethylpenicillin  Powder for oral liquid:  250 mg/5  mL (as potassium) .,Complementary
5,Medicines For Neurological Disorders,Infections (Severe),procaine benzylpenicillin * Powder for injection:  1 g (=1  million  IU); 3 g (=3  million  IU) in vial.,Complementary
5,Medicines For Neurological Disorders,Isoniazid + Pyridoxine + Sulfamethoxazole +,trimethoprim  Tablet (scored): 300 mg + 25  mg + 800  mg + 160  mg,Complementary
5,Medicines For Neurological Disorders,Isoniazid + Pyridoxine + Sulfamethoxazole +,valganciclovir*  Tablet:  450 mg (as hydrochloride) .,Complementary
5,Medicines For Neurological Disorders,Isoniazid + Pyridoxine + Sulfamethoxazole +,oseltamivir * Capsule: 30 mg; 45  mg; 75  mg (as phosphate).,Complementary
5,Medicines For Neurological Disorders,Isoniazid + Pyridoxine + Sulfamethoxazole +,Powder for oral liquid: 6 mg/mL (as phosphate) [c].,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,− bensera zide (for carbidopa)  Tablet:  100 mg + 10  mg; 100  mg +  25 mg; 250  mg + 25  mg.,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,Oral liquid: 10 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,Tablet: 10 mg.,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,acetylsalicylic acid  Tablet: 300 mg to 50 0 mg.,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,Oral liquid:  100 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,Tablet:  200 mg; 400  mg.,Complementary
5,Medicines For Neurological Disorders,Levodopa +  Carbidopa,paracetamol (acetaminophen)  Oral liquid:  120 mg/5  mL or 125  mg/5  mL*; 250  mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],benzathine benzylpenicillin  Powder for injection:  1.2 million  IU (≈ 900 mg) in vial [c]; 2.4 million  IU (≈ 1.8 g) in,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],cefalexin   Powder for oral liquid : 125 mg/5  mL; 250  mg/5  mL (anhydrous).,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],Tablet (dispersible):  125 mg [c]; 250 mg [c].,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],cefazolin  a Powder for injection: 1 g (as sodium salt) in vial.,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],WHO Model List of Essential Medicines – 24th List (2025 ) page 14 metronidazole   Injection:  500 mg in 100  mL vial.,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],Oral liquid:  200 mg/5  mL (as benzoate) .,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],Suppository:  500 mg; 1  g.,Complementary
5,Medicines For Neurological Disorders,Malnutrition [C],Tablet:  200 mg; 250 mg; 400 mg; 500 mg.,Complementary
5,Medicines For Neurological Disorders,Moderate),WHO Model List of Essential Medicines – 24th List (2025 ) page 12 ampicillin  Powder for injection:  500 mg; 1  g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Moderate),gentamicin  Injection: 10 mg/mL (as sulfate) ; 40 mg/mL  (as sulfate)  in 2 mL vial.,Complementary
5,Medicines For Neurological Disorders,Moderate),WHO Model List of Essential Medicines – 24th List (2025 ) page 16 ceftriaxone * a  Powder for injection:  250 mg; 500 mg; 1 g; 2 g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Moderate),cefuroxime  Powder for injection: 250 mg; 750 mg; 1.5 g (as sodium) in vial .,Complementary
5,Medicines For Neurological Disorders,Moderate),ciprofloxacin  Oral liquid : 250 mg/5  mL (anhydrous) [c].,Complementary
5,Medicines For Neurological Disorders,Moderate),Solution for IV infusion:  2 mg/mL (as hyclate)  [c].,Complementary
5,Medicines For Neurological Disorders,Moderate),pharyngitis in children (EMLc only)  Powder for oral liquid:  125 mg/5  mL; 250  mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Moderate),Powder for injection:  500 mg in vial .,Complementary
5,Medicines For Neurological Disorders,Neurodevelopmental Disorders In Children Exposed,to valproic acid (sodium valproate) in the womb.  Oral liquid:  200 mg/5  mL.,Core
5,Medicines For Neurological Disorders,Neurodevelopmental Disorders In Children Exposed,Tablet (crushable):  100 mg.,Core
5,Medicines For Neurological Disorders,Neurodevelopmental Disorders In Children Exposed,Tablet (enteric -coated):  200 mg; 500  mg.,Core
5,Medicines For Neurological Disorders,Neurodevelopmental Disorders In Children Exposed,ethosuximide  Capsule:  250 mg.,Complementary
5,Medicines For Neurological Disorders,Neurodevelopmental Disorders In Children Exposed,Oral liquid:  250 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Neurodevelopmental Disorders In Children Exposed,Solution for infusion:  5 mg/mL; 10  mg/mL; 15  mg/mL in 100  mL bag.,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,pretomanid  Tablet: 200 mg.,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,pyrazinamide  Tablet:  400 mg; 500  mg,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,Tablet (dispersible): 150 mg.,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,rifampicin  Oral liquid:  20 mg/mL [c].,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,rifapentine  Tablet:  150 mg; 300  mg.,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,"Tablet (dispersible, scored):  150 mg [c].",Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,streptomycin [c]  Powder for injection:  1 g (as sulfate) in vial.,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,amphotericin B * Powder for injection:  50 mg (liposomal complex)  in vial .,Complementary
5,Medicines For Neurological Disorders,P-Aminosalicylic Acid).,Powder for injection: 50 mg (as sodium deoxycholate) in vial,Complementary
5,Medicines For Neurological Disorders,Potassium Iodide  Saturated Solution.,- valaciclovir  (oral)  Oral liquid:  200 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Potassium Iodide  Saturated Solution.,Powder for solution for infusion : 250 mg (as sodium dihydrate ) in,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,abacavir  Tablet:  300 mg (as sulfate).,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,lamivudine  Oral liquid:  50 mg/5  mL [c].,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,Tablet:  150 mg.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,tenofovir disoproxil fumarate †  Tablet: 300 mg (tenofovir disoproxil fumarate – equivalent to,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,zidovudine  Capsule:  250 mg.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,Oral liquid:  50 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,Solution for IV infusion:  10 mg/mL in 20  mL vial.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,Tablet:  300 mg.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,efavirenz  Tablet: 600 mg.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,nevirapine  a  Oral liquid:  50 mg/5  mL.,Complementary
5,Medicines For Neurological Disorders,Quality Products Are Available.,Tablet  (dispersible) : 50 mg; 200  mg.,Complementary
5,Medicines For Neurological Disorders,Quality.,amikacin  Injection:  250 mg/mL (as sulfate) in 2  mL vial.,Complementary
5,Medicines For Neurological Disorders,Quality.,amoxicillin + clavulanic acid*  Powder for oral liquid: 250 mg (as trihydrate) + 62.5  mg (as potassium,Complementary
5,Medicines For Neurological Disorders,Rhodesiense  Infection.,pentamidine * Powder for injection: 300 mg (as isetionate) in vial.,Complementary
5,Medicines For Neurological Disorders,Rhodesiense Infection.,eflornithine*  Injection: 200 mg/mL (hydrochloride)  in 50 mL bottle.,Complementary
5,Medicines For Neurological Disorders,Rituximab *,*including quality -assured biosimilars  Injection (intravenous): 500 mg/50  mL in 50  mL vial.,Complementary
5,Medicines For Neurological Disorders,Rituximab *,− trihexyphenidyl  Injection:  5 mg (lactate) in 1  mL ampoule.,Complementary
5,Medicines For Neurological Disorders,Rituximab *,Tablet:  2 mg (hydrochloride).,Complementary
5,Medicines For Neurological Disorders,Salt) In Vial.,WHO Model List of Essential Medicines – 24th List (2025 ) page 8 cefotaxime*  Powder for injection: 250 mg; 500 mg; 1 g; 2 g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Salt) In Vial.,ceftriaxone *a  Powder for injection:  250 mg; 500 mg; 1 g (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Salt) In Vial.,Powder for injection:  1 g (sodium succinate) in vial.,Complementary
5,Medicines For Neurological Disorders,Salt) In Vial.,gentamicin   Injection: 10 mg/mL (as sulfate); 4 0 mg/mL (as sulfate) in 2  mL vial.,Complementary
5,Medicines For Neurological Disorders,Salt) In Vial.,meropenem* a Powder for injection:  500 mg (as trihydrate); 1 g (as trihydrate) in vial,Complementary
5,Medicines For Neurological Disorders,Salt) [C].,bedaquiline  Tablet: 20 mg [c]; 100  mg.,Complementary
5,Medicines For Neurological Disorders,Salt) [C].,delamanid  Tablet (dispersible): 25 mg [c].,Complementary
5,Medicines For Neurological Disorders,Salt) [C].,Tablet:  50 mg.,Complementary
5,Medicines For Neurological Disorders,Salt) [C].,ethambutol  Tablet:  100 mg; 400 mg (hydrochloride).,Complementary
5,Medicines For Neurological Disorders,Salt) [C].,Tablet (dispersible ): 10 0 mg [c],Complementary
5,Medicines For Neurological Disorders,Salt)/5  Ml [C].,Tablet: 500 mg (as trihydrate) + 125  mg (as potassium salt).,Complementary
5,Medicines For Neurological Disorders,Salt)/5  Ml [C].,Tablet (dispersible):  250 mg (as trihydrate) + 62. 5 mg (as potassium,Complementary
5,Medicines For Neurological Disorders,Seizures .,levetiracetam  Oral liquid : 100 mg/mL,Core
5,Medicines For Neurological Disorders,Seizures .,Tablet: 250 mg; 500  mg; 750  mg; 1 000 mg.,Core
5,Medicines For Neurological Disorders,Seizures .,- midazolam ( injection ) Injection : 2 mg/mL in 1 mL ampoule; 4  mg/mL in 1 mL ampoule.,Core
5,Medicines For Neurological Disorders,Seizures .,magnesium sulfate * Injection:  0.5 g/mL in 2 mL ampoule  (equivalent to 1  g in 2  mL; 50%,Core
5,Medicines For Neurological Disorders,Sulfamethoxazole +,trimethoprim   Injection:  80 mg + 16  mg/mL in 5   mL ampoule; 80  mg + 16  mg/mL in 10 mL,Complementary
5,Medicines For Neurological Disorders,The Preferred Choice For Acute,bacterial meningitis in neonates.  Powder for injection:  500 mg (as trihydrate); 1  g (as trihydrate) in vial.,Complementary
5,Medicines For Neurological Disorders,Vial.,benzylpenicillin  Powder for injection:  600 mg (= 1  million  IU); 3 g (= 5  million  IU) (sodium  or,Complementary
5,Medicines For Neurological Disorders,Vial.,dapsone  Tablet:  25 mg; 50  mg; 100  mg.,Complementary
5,Medicines For Neurological Disorders,Vial.,rifampicin  Oral liquid: 20 mg/mL [c].,Complementary
5,Medicines For Neurological Disorders,Vial.,Solution for infusion : 25 mg/mL (as sodium) in vial.,Complementary
5,Medicines For Neurological Disorders,Vial.,Tablet:  200 mg.,Complementary
5,Medicines For Neurological Disorders,Where Hospital Care Is Not Achievable.,spectinomycin  Powder for injection:  2 g (as hydrochloride) in vial.,Complementary
5,Medicines For Neurological Disorders,With Who Treatemnt Guidelines .,abacavir + dolutegravir + lamivudine  [c] Tablet (dispersible): 60 mg (as sulfate)  + 5 mg + 30  mg.,Complementary
5,Medicines For Neurological Disorders,With Who Treatemnt Guidelines .,"abacavir + lamivudine  Tablet (dispersible, scored):  120 mg (as sulfate) + 60  mg.",Complementary
5,Medicines For Neurological Disorders,With Who Treatemnt Guidelines .,dolutegravir + lamivudine + tenofovir  Tablet: 50 mg + 300  mg + 300  mg (tenofovir disoproxil fumarate –,Complementary
7,Medicines For Cystic Fibrosis,Infection.,elexacaftor + tezacaftor + ivacaftor   Granules:  80 mg + 40  mg + 60  mg; 100  mg + 50  mg + 75  mg in,Core
7,Medicines For Cystic Fibrosis,Sachet .,Tablet : 50 mg + 25  mg + 37.5  mg; 100  mg + 50  mg + 75  mg.,Core
7,Medicines For Cystic Fibrosis,Sachet .,ivacaftor  Granules: 59.5 mg; 75  mg in sachet .,Core
7,Medicines For Cystic Fibrosis,Sachet .,Tablet:  75 mg; 150  mg.,Core
7,Medicines For Cystic Fibrosis,Sachet .,pancreatic enzymes .[c] Capsule (modified release)*:  10 000 lipase units + 8000  amylase,Complementary
8,Immunomodulators  And Antineoplastics,Asparaginase *,*including quality -assured biosimilars  Powder for injection:  10 000 IU in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Asparaginase *,bendamustine  Injection:  45 mg/0.5  mL; 180  mg/2  mL.,Complementary
8,Immunomodulators  And Antineoplastics,Asparaginase *,bleomycin  Powder for injection:  15 000 IU (as sulfate) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Blinatumomab*,*including quality -assured biosimilars  Powder for c oncentrate for solution for infusion: 35 micrograms;,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Injection:  3 mg/mL in 10  mL ampoule ; 7.5 mg/mL in 2  mL,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Tablet:  5 mg; 15 mg; 25 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),capecitabine  Tablet:  150 mg; 500  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),carboplatin  Injection:  50 mg/5  mL; 150  mg/15  mL; 450  mg/45  mL;,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),chlorambucil  Tablet:  2 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),WHO Model List of Essential Medicines – 24th List (2025 ) page 29 cisplatin  Injection:  10 mg/10  mL; 20  mg/20  mL; 50 mg/50  mL;,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),cyclophosphamide  Powder for injection:  500 mg; 1 g; 2 g in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),cytarabine  Injection: 100 mg/mL  in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection:  100 mg in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),dacarbazine  Powder for injection:  100 mg; 200  mg in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),dactinomycin  Powder for injection:  500 micrograms in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),daunorubicin  Injection : 2 mg/mL; 5  mg/mL  (as hydrochloride)  in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection : 20 mg; 50 mg (as hydrochloride) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),WHO Model List of Essential Medicines – 24th List (2025 ) page 30 docetaxel  Injection: 20 mg/mL; 40  mg/mL.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),doxorubicin  Injection: 2 mg/mL  (hydrochloride)  in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection:  10 mg; 50  mg (hydrochloride) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),"doxorubicin  (as pegylated liposomal ) Injection:  2 mg/mL (hydrochloride) in 10  mL, 25  mL vial",Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),"etoposide  Capsule:  50 mg, 100  mg.",Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Injection:  20 mg/mL in 5  mL ampoule.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection : 100  mg (as phosphate)  in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),fludarabine  Powder for injection: 50 mg (phosphate) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Tablet:  10 mg,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),fluorouracil  Injection:  50 mg/mL in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),gemcitabine  Powder for injection:  200 mg; 1 g in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),ifosfamide  Powder for injection:  500 mg; 1  g; 2 g in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),irinotecan  Injection:  40 mg/2  mL in 2  mL vial; 100  mg/5  mL in 5  mL vial;,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),melphalan  Tablet: 2 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection: 50 mg in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),mercaptopurine  Tablet:  50 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Oral liquid : 20 mg/mL  [c].,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Injection : 50 mg/2  mL.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection:  50 mg (as sodium) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Tablet:  2.5 mg (as sodium).,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),oxaliplatin  Injection: 50 mg/10  mL in 10  mL vial; 100  mg/20  mL in 20  mL,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),Powder for injection:  50 mg; 100 mg in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Calcium Folinate  (Leucovorin Calcium),WHO Model List of Essential Medicines – 24th List (2025 ) page 32 paclitaxel  Injection : 6 mg/mL  in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Cancer,everolimus   Tablet: 2.5 mg; 5  mg; 7.5  mg; 10  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Cancer,Tablet (dispersible):  2 mg; 3  mg; 5  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Cancer,- zanubrutinib  Capsule:  140 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Filgrastim *,*including quality -assured biosimilars  Injection: 120 micrograms/0.2  mL; 300  micrograms/0.5  mL;,Complementary
8,Immunomodulators  And Antineoplastics,Filgrastim *,Injection:  300 micrograms/mL in 1  mL vial ;,Complementary
8,Immunomodulators  And Antineoplastics,Leukaemia,nilotinib  Capsule: 150 mg; 200  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,azathioprine  Oral liquid:  10 mg/mL  [c].,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,Powder for injection: 50 mg [c]; 100 mg (as sodium salt) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,Tablet: 25 mg [c].,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,Tablet (scored): 50 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,ciclosporin  Capsule: 25 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,Oral liquid: 100 mg/mL  [c].,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,tacrolimus  Capsule (immediate -release): 0.5 mg; 0.75  mg; 1  mg; 2  mg;,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,Granules for oral supsension: 0.2 mg; 1  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Or Pre -Filled Pen.,Injection: 5 mg/mL  in 1 mL vial .,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,*including quality -assured biosimilars  Injection:  3750  units/5  mL in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,Powder for injection : 3750  units  in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,procarbazine  [c] Capsule:  50 mg (as hydrochloride).,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,realgar -Indigo naturalis formulation  Tablet: 270 mg (containing tetra -arsenic tetra -sulfide 30  mg).,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,vinblastine  Injection:  10 mg/10 mL (sulfate)  in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,Powder for injection:  10 mg (sulfate) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,vincristine  Injection : 1 mg/mL  (sulfate); 2  mg/2  mL (sulfate) in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,Powder for injection:  1 mg; 5  mg (sulfate) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,vinorelbine  Capsule: 20 mg; 30  mg; 80  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,"Injection:  10 mg/mL in 1  mL, 5 mL vial.",Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,all-trans retinoid acid (ATRA)  Capsule:  10 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,bortezomib  Powder for injection: 3.5 mg in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,dasatinib  Tablet:  20 mg; 50  mg; 70  mg; 80  mg; 100  mg; 140  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Pegaspargase *,"- gefitinib  Tablet: 100 mg, 150  mg.",Complementary
8,Immunomodulators  And Antineoplastics,Pegfilgrastim *,*includ ing quality -assured biosimilars  Injection: 6 mg/0.6  mL in pre -filled syringe.,Complementary
8,Immunomodulators  And Antineoplastics,Regimens,lenalidomide  Capsule: 25 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Rituximab*,*including quality -assured biosimilars  Injection (intravenous):  100 mg/10  mL in 10  mL vial;,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,- prednisone  Oral liquid: 5 mg/mL  [c].,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,Tablet:  5 mg; 25  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,WHO Model List of Essential Medicines – 24th List (2025 ) page 36 tamoxifen  Tablet:  10 mg; 20  mg (as citrate).,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,allopurinol [c]  Powder for injection : 500 mg (as sodium),Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,Tablet:  100 mg; 300  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,"mesna  Injection *: 100 mg/mL in 2 mL, 4 mL, 10 mL ampoule .",Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,Tablet:  400 mg; 600  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,rasburicase  Powder  and solvent  for solution for infusion : 1.5 mg (with 1  mL,Complementary
8,Immunomodulators  And Antineoplastics,Sodium Succinate) In Vial.,Solution for infusion : 4 mg/100  mL in 100  mL bottle.,Complementary
8,Immunomodulators  And Antineoplastics,Trastuzumab*,*including quality -assured biosimilars  Powder for injection:  60 mg; 150  mg; 440  mg in vial .,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,thalidomide  Capsule: 50 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,- enzalutamide  Tablet: 250 mg; 500  mg.,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,Aromatase inhibitors)  Tablet:  1 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,- nilutamide  Tablet: 50 mg.,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,dexamethasone  Injection: 4 mg/mL dexamethasone phosphate (as sodium,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,Oral liquid:  2 mg/5  mL (as sodium phosphate)  [c].,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,Tablet: 2 mg [c]; 4 mg (as dexamethasone base) .,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,hydrocortisone  Powder for injection: 100 mg (as sodium succinate) in vial.,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,- triptorelin  Injection: 7.5 mg; 22.5  mg in pre -filled syringe .,Complementary
8,Immunomodulators  And Antineoplastics,Type And≥ 50% Pd-L1 Expression ^,methylprednisolone  [c] Powder for injection : 40 mg (as sodium succinate); 125 mg (as,Complementary
8,Immunomodulators  And Antineoplastics,Units + 1000  Protease Units.,*including quality -assured biosimilars  Injection:  10 mg/0.2  mL [c]; 20 mg/0.2 mL [c]; 20 mg/0  4 mL [c];,Complementary
